Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elyse R Park, Ph.D.

Co-Author

This page shows the publications co-authored by Elyse Park and Daniel Hall.
Connection Strength

7.604
  1. A Multi-step Approach to Adapting a Mind-Body Resiliency Intervention for Fear of Cancer Recurrence and Uncertainty in Survivorship (IN FOCUS). Glob Adv Health Med. 2022; 11:21649561221074690.
    View in: PubMed
    Score: 0.983
  2. The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors. Cancer. 2022 04 01; 128(7):1532-1544.
    View in: PubMed
    Score: 0.976
  3. Responding to COVID-19 Stress: Disseminating Mind-Body Resiliency Approaches. Glob Adv Health Med. 2020; 9:2164956120976554.
    View in: PubMed
    Score: 0.908
  4. Perceived cancer-related benefits of quitting smoking and associations with quit intentions among recently diagnosed cancer patients. J Health Psychol. 2021 05; 26(6):831-842.
    View in: PubMed
    Score: 0.813
  5. Lung Cancer Screening Uncertainty among Patients Undergoing LDCT. Am J Health Behav. 2018 01 01; 42(1):69-76.
    View in: PubMed
    Score: 0.742
  6. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer. 2017 05; 25(5):1401-1407.
    View in: PubMed
    Score: 0.690
  7. The Association of Illness-Related Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases. J Rheumatol. 2022 Apr 01.
    View in: PubMed
    Score: 0.249
  8. Corrigendum to "Examining the effects of stress and psychological distress on smoking abstinence in cancer patients" [Prev. Med. Rep. 23 (2021) 101402]. Prev Med Rep. 2022 Feb; 25:101693.
    View in: PubMed
    Score: 0.245
  9. Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic. J Affect Disord. 2021 10 01; 293:373-378.
    View in: PubMed
    Score: 0.236
  10. Examining the effects of stress and psychological distress on smoking abstinence in cancer patients. Prev Med Rep. 2021 Sep; 23:101402.
    View in: PubMed
    Score: 0.234
  11. A Comprehensive Resiliency Framework: Theoretical Model, Treatment, and Evaluation. Glob Adv Health Med. 2021; 10:21649561211000306.
    View in: PubMed
    Score: 0.232
  12. Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial. Gen Hosp Psychiatry. 2021 Jan-Feb; 68:111-112.
    View in: PubMed
    Score: 0.226
  13. A Pilot Mind-Body Resiliency Intervention Targeting Fear of Recurrence among Cancer Survivors. J Psychosom Res. 2020 Aug 10; 137:110215.
    View in: PubMed
    Score: 0.222
  14. Theoretical Rationale and Case Illustration of Mindfulness-Based Cognitive Therapy for Fear of Cancer Recurrence. J Clin Psychol Med Settings. 2019 12; 26(4):449-460.
    View in: PubMed
    Score: 0.212
  15. Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change. J Oncol Pract. 2019 09; 15(9):e787-e797.
    View in: PubMed
    Score: 0.206
  16. Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis. Psychooncology. 2018 11; 27(11):2546-2558.
    View in: PubMed
    Score: 0.191
  17. Project reach: Piloting a risk-tailored smoking cessation intervention for lung screening. J Health Psychol. 2020 09; 25(10-11):1472-1482.
    View in: PubMed
    Score: 0.188
  18. A Perspective on the Similarities and Differences Between Mindfulness and Relaxation. Glob Adv Health Med. 2020; 9:2164956120905597.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.